ClinicalTrials.gg
RecruitingNCT07879781MunichFluUpdated Oct 19, 2026

Respiratory Viral Infections Following Oktoberfest Attendance

An observational study in Respiratory Viral Infections Associated With Oktoberfest Attendance, sponsored by LMU Klinikum. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by LMU Klinikum · Observational

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 19, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
4,000
Ages
18 Years and older
Sex
All
01

Study summary

The MunichFlu study is a prospective observational study investigating the incidence and etiology of respiratory viral infections following attendance at the Munich Oktoberfest, one of the world's largest mass gathering events.

Participants will be recruited during the Oktoberfest after providing informed consent. One to two weeks after the end of the festival, participants will receive an online follow-up questionnaire collecting information on demographic characteristics, medical history, Oktoberfest attendance, and the occurrence of respiratory symptoms or other infectious illnesses after their visit.

Participants reporting symptoms suggestive of an acute respiratory infection will be offered an optional nasal and/or throat swab for molecular detection and identification of the causative respiratory virus. In parallel, wastewater samples will be collected at the Oktoberfest venue and analyzed for circulating respiratory viruses to assess environmental viral surveillance.

To account for seasonal variations in respiratory virus circulation, parallel population-based surveys will be conducted in the German cities of Regensburg and Nuremberg during the same study period. The combined epidemiological, virological, and environmental surveillance data will provide a comprehensive assessment of respiratory viral infections associated with Oktoberfest attendance.

02

Conditions studied

  • Respiratory Viral Infections Associated With Oktoberfest Attendance
03

In context

Lead sponsor

LMU Klinikum is the lead sponsor of 53 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population includes individuals attending the Munich Oktoberfest and control participants from Regensburg and Nuremberg, Germany. Participants will be followed prospectively to assess respiratory symptoms and respiratory viral infections after Oktoberfest attendance. Control cohorts will be used to account for seasonal variations in respiratory virus circulation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged ≥18 years attending the Munich Oktoberfest during the study period, or reside in one of the predefined control regions (Regensburg or Nuremberg) Ability to provide informed consent Willingness to complete the study questionnaire during follow-up

Exclusion criteria

Exclusion Criteria:

Refusal or inability to provide informed consent Inability to complete the follow-up questionnaire

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
4,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Oktoberfest Attendance Cohort

    Participants attending Oktoberfest and followed prospectively for respiratory symptoms and viral infections after attendance.

  • Regensburg Control Cohort

    Participants from Regensburg surveyed during the same period to assess background seasonal respiratory virus circulation.

  • Nuremberg Control Cohort

    Participants from Nuremberg surveyed during the same period to assess background seasonal respiratory virus circulation.

06

What researchers measure

Primary outcomes

  1. Incidence of respiratory viral infections following Oktoberfest attendance

    Proportion of participants developing symptoms of an acute respiratory infection within the follow-up period after Oktoberfest attendance, with optional molecular confirmation of respiratory viral pathogens.

    Time frame: 1-2 weeks after Oktoberfest attendance

Secondary outcomes

  1. Incidence of respiratory symptoms after Oktoberfest attendance

    Occurrence and type of respiratory symptoms, including cough, sore throat, fever, nasal congestion, fatigue, and other symptoms suggestive of acute respiratory infection.

    Time frame: 1-2 weeks after Oktoberfest attendance

  2. Identification of respiratory viral pathogens

    Detection and identification of respiratory viruses from nasal and/or throat swabs collected from symptomatic participants using molecular diagnostic methods.

    Time frame: 1-2 weeks after Oktoberfest attendance

  3. Spectrum of respiratory viruses detected in wastewater samples

    Detection and characterization of respiratory viral pathogens in wastewater samples collected at the Oktoberfest venue during the festival period.

    Time frame: During Oktoberfest

  4. Comparison of respiratory infection rates between Oktoberfest attendees and control populations

    Comparison of the incidence of respiratory symptoms and suspected respiratory infections between Oktoberfest attendees and participants from control cities (Regensburg and Nuremberg).

    Time frame: 1-2 weeks after the study period

  5. Association between Oktoberfest exposure characteristics and respiratory infections

    Association between characteristics of Oktoberfest attendance (e.g., number of visits, duration of stay, crowd exposure, indoor/outdoor activities) and occurrence of respiratory infections.

    Time frame: 1-2 weeks after Oktoberfest attendance

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07879781
Lead sponsor
LMU Klinikum
Responsible party
Prof. Dr. Stefan Brunner (Prof. Dr. med., LMU Klinikum) — Principal investigator
First posted
Oct 19, 2026
Start date
Sep 19, 2026
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Stefan Brunner, MD
Contact
Stefan.Brunner@med.uni-muenchen.de
+49 89 44000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion